TNNT2 and peripheral arterial disease: Similar findings were reported the same year by Linnemann et al. [21] on a cohort of 1041 consecutive PAD patients undergoing endovascular peripheral artery revascularization, where detectable hs-cTnT was associated with increased one-year total mortality and amputation rates even after adjusting for age, kidney function, smoking, diabetes, and CLTI.